Jan Brinkman
Keine laufenden Positionen mehr
Karriereverlauf von Jan Brinkman
Ehemalige bekannte Positionen von Jan Brinkman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NANOMIX CORPORATION | Direktor/Vorstandsmitglied | 25.09.2014 | 23.02.2016 |
Ausbildung von Jan Brinkman
| Erasmus University Rotterdam | Doctorate Degree |
| INSEAD | Masters Business Admin |
| University of Florence | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 2 |
| Niederlande | 2 |
| Frankreich | 2 |
Operativ
| Doctorate Degree | 2 |
| Director/Board Member | 1 |
| Masters Business Admin | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
- Börse
- Insiders
- Jan Brinkman
- Erfahrung
